These “super me-too” drugs are then engineered to work better than currently available ones. GSK has licensed an antibody drug conjugate, a type of targeted chemotherapy, from Hansoh Pharma in ...

These first copycat drugs, usually called me-too drugs by industry insiders, created a problem that has bedeviled the industry thereafter--the propensity for some of the newer versions of the drug ...

[3] With the increased burden of paying more for prescription drugs, consumers will become more discerning about the concept of value. For example, more expensive "me-too" drugs may suffer a ...

But interpreting patent law in a way that makes reach-through claims to drug target patents difficult to obtain actually may not be in the best interest of public health. The 'me-too' drug problem ...